ILMN ILMN

Illumina Stock Price

374.42
4.99 (1.35%)
Upgrade to Real-Time
Regular Market
374.42
Volume 682,878
Bid Price 374.33
Ask Price 374.43
News -
Day High 376.06

Low
335.68

52 Week Range

High
555.77

Day Low 366.40
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Illumina Inc ILMN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
4.99 1.35% 374.42 14:11:28
Open Price Low Price High Price Close Price Prev Close
368.1477 366.40 376.06 369.43
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
18,484 682,878 $ 371.24 $ 253,514,790 - 335.68 - 555.77
Last Trade Time Type Quantity Stock Price Currency
14:11:32 1 $ 374.39 USD

Period:

Draw Mode:

Illumina Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 58.52B 156.30M 136.13M $ 3.24B $ 685.70M 4.45 57.70
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - -13.10k 1.90%

more financials information »

Illumina News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ILMN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week365.70376.06341.03356.891,171,3498.722.38%
1 Month392.25393.92341.03369.03965,206-17.83-4.55%
3 Months449.58453.92341.03399.04894,573-75.16-16.72%
6 Months431.53526.00341.03433.39756,080-57.11-13.23%
1 Year341.19555.77335.68417.79899,19133.239.74%
3 Years321.50555.77196.78340.991,038,23652.9216.46%
5 Years121.63555.77120.00299.60991,856252.79207.84%

Illumina Description

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates revenue from sequencing tools and dedicated consumables (76% of 2020 sales). Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications. Services account for 16% of sales and include basic maintenance services, clinical lab applications (such as noninvasive prenatal, oncology, and rare-disease screening), and whole genome sequencing.


Your Recent History
NASDAQ
ILMN
Illumina
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.